{"nct_id":"NCT06376045","title":"A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-05-24","start_date_type":"ACTUAL","primary_completion_date":"2026-08-10","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-02","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AMGN"]}